BioWorld MedTech

Aug. 20, 2014

Financings: HQC closes debut fund at $110M to invest in healthcare sectors

HealthQuest Capital (HQC; Menlo Park, California), a new fund sponsored by Sofinnova Ventures, reported the closing of its debut fund at the hard cap of $110 million and in excess of the initial fund target of $50 million. Read More

Nasal brush test could safely diagnose early prion infection in patients

Medtronic sees profit decline, improvement in sales for 1Q14

Protectionist policy being pursued: China to promote domestic devices among its top hospital facilities

HIT Bits: Firm shows how crucial EMRs are in the big data revolution

Agreements/contracts: Cytori and BARDA continue cell development for thermal burns

Daily M&A: LeMaitre Vascular acquires Xenotis for $7.7 million

Product briefs

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 20, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...